145 related articles for article (PubMed ID: 35065063)
1. Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.
de Vries HJC; de Laat M; Jongen VW; Heijman T; Wind CM; Boyd A; de Korne-Elenbaas J; van Dam AP; Schim van der Loeff MF;
Lancet Infect Dis; 2022 May; 22(5):706-717. PubMed ID: 35065063
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
Ross JD; Harding J; Duley L; Montgomery AA; Hepburn T; Tan W; Brittain C; Meakin G; Sprange K; Thandi S; Jackson L; Roberts T; Wilson J; White J; Dewsnap C; Cole M; Lawrence T
Health Technol Assess; 2019 May; 23(20):1-104. PubMed ID: 31099330
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L;
Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291
[TBL] [Abstract][Full Text] [Related]
4. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D;
Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous clearance of asymptomatic anogenital and pharyngeal
Teker B; de Vries H; Heijman T; van Dam A; Schim van der Loeff M; Jongen VW
Sex Transm Infect; 2023 Jun; 99(4):219-225. PubMed ID: 35820778
[TBL] [Abstract][Full Text] [Related]
6. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
[TBL] [Abstract][Full Text] [Related]
7.
Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.
Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M
Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in
Gubenšek U; de Laat M; Foerster S; Boyd A; van Dam AP
Antibiotics (Basel); 2022 Feb; 11(3):. PubMed ID: 35326763
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.
Kirkcaldy RD; Weinstock HS; Moore PC; Philip SS; Wiesenfeld HC; Papp JR; Kerndt PR; Johnson S; Ghanem KG; Hook EW
Clin Infect Dis; 2014 Oct; 59(8):1083-91. PubMed ID: 25031289
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review.
Hathorn E; Dhasmana D; Duley L; Ross JD
Syst Rev; 2014 Sep; 3():104. PubMed ID: 25239090
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains.
Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
Sex Transm Dis; 2018 Feb; 45(2):127-131. PubMed ID: 28876284
[TBL] [Abstract][Full Text] [Related]
13. Neisseria gonorrhoeae and fosfomycin: Past, present and future.
Tesh LD; Shaeer KM; Cho JC; Estrada SJ; Huang V; Bland CM; DiMondi VP; Potter AN; Hussein G; Bookstaver PB
Int J Antimicrob Agents; 2015 Sep; 46(3):290-6. PubMed ID: 26145201
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Allen GP; Deao KM; Hill SA; Schipelliti SM; Tran T
Int J Antimicrob Agents; 2021 Oct; 58(4):106417. PubMed ID: 34391903
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
[TBL] [Abstract][Full Text] [Related]
16. Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial.
Bížová B; Procházka P; Nyčová E; Bořil P; Kubele J; Poláková A; Zemanová Z; Unemo M; Rob F
Clin Microbiol Infect; 2024 Feb; 30(2):211-215. PubMed ID: 37981059
[TBL] [Abstract][Full Text] [Related]
17. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.
Cole MJ; Tan W; Fifer H; Brittain C; Duley L; Hepburn T; Lawrence T; Montgomery AA; Sprange K; Thandi S; Churchward C; Tripodo F; Woodford N; Ross JDC
J Antimicrob Chemother; 2020 Feb; 75(2):449-457. PubMed ID: 31670808
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of alternative antibiotics for susceptibility of gonococcal isolates from China.
Yang F; Yan J; Zhang J; van der Veen S
Int J Antimicrob Agents; 2020 Feb; 55(2):105846. PubMed ID: 31760083
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.
Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
